Hematology

In a phase 3 trial involving 44 patients aged 12 to 35, exa-cel was found to provide remarkable results….

A recent multicentre study has shown that venetoclax combined with decitabine as an effective first-line treatment for older patients with acute myeloid leukaemia.

A groundbreaking study has developed a blood-based ageing clock capable of predicting biological age and providing insights into the ageing process…

A phase 3 clinical trial, explorer8, has demonstrated the efficacy and safety of concizumab…

A recent international clinical trial involving 850 patients has revealed that a liberal blood transfusion strategy significantly improves neurological outcomes…

A ground-breaking study has identified circulating cell-free DNA as a potential biomarker for predicting early relapse in patients with aggressive B-cell lymphoma…

A new study shows that adding itacitinib to standard GvHD prophylaxis in haplo-HCT is safe and well-tolerated.

A study has revealed that cognitive decline in older adults diagnosed with hematologic malignant neoplasms is similar to the cognitive decline in normal ageing…